SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases.
DOVER, DE – The Delaware State Senate has unanimously passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).
COLUMBIA, S.C. – “Nearly 40,000 South Carolinians will be diagnosed with cancer this year. Tobacco is the leading cause of preventable death in the United States.
ACS CAN’s newest campaign highlights the need to build on proven progress in groundbreaking research with sustained funding increase for the National Institutes of Health and National Cancer Institute.
ACS CAN urges Congress to Fight Cancer and Make Time, literally, for more of life’s moments for patients and survivors by prioritizing cancer research.